Report Highlights

Anti-reflective coatings in the U.S.: Market Overview

The U.S. anti-reflective coatings market was valued at USD 1.42 billion in 2024 and is forecast to reach USD 2.28 billion by 2032. Demand spans prescription eyewear, defense optics, semiconductor lithography optics, display panels, and solar cover glass. The structure is fragmented at the lens-coating level, with Essilor of America and Hoya Vision Care operating large coating lines alongside hundreds of independent ophthalmic laboratories. Consumer lens demand accounts for the largest unit volume, while defense and semiconductor optics generate higher value per unit.

Government has been the dominant force in defense and semiconductor optics, where procurement and subsidy decide who builds coating capacity. Private enterprise has led in ophthalmic lenses and consumer electronics, where coating innovation is funded from company balance sheets. Trade policy sits between these two worlds, because tariffs on imported optical components have shifted volume toward domestic coating lines.

Policy-driven growth in anti-reflective coatings across the U.S.

The CHIPS and Science Act of 2022 (Public Law 117-167) allocates USD 39 billion in manufacturing incentives, administered by the Commerce Department's CHIPS Program Office, and USD 11 billion for research through the National Semiconductor Technology Center and the National Advanced Packaging Manufacturing Program. Fabs receiving awards, including Intel's Ohio site and TSMC's Arizona campus, require precision lithography and metrology optics that carry multi-layer AR coatings. This converts a federal subsidy into direct coating demand at tool suppliers.

The Defense Production Act Title III (50 U.S.C. 4533) funds domestic capacity in critical materials and optics, administered by the Department of Defense's Office of Industrial Base Policy, which steers military sighting and night-vision optics toward U.S. coaters. Section 301 tariffs apply a 25% duty to many Chinese optical components under Lists 1 and 3, raising landed costs for imported lens blanks. Together these mechanisms shift volume from imports to domestic thin-film lines.

Regulatory barriers and compliance costs for coating operators

Ophthalmic lenses are regulated as Class II medical devices under 21 CFR Part 886, administered by the FDA's Center for Devices and Radiological Health. Changes to a coating formulation can require a 510(k) premarket notification, which typically takes several months and carries preparation and user-fee costs for the sponsor. Prescription lens coatings must also meet ANSI Z80.1-2020, creating third-party optical testing expenses for laboratories.

EPA's TSCA Section 8(a)(7) rule under the Toxic Substances Control Act, as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act, requires manufacturers and importers to report PFAS uses, administered by the EPA Office of Pollution Prevention and Toxics. Maine's PFAS in products law (38 M.R.S. §1614) and Minnesota's Amara's Law (Minn. Stat. §116.943) restrict intentionally added PFAS in designated categories. Fluorinated AR top coats therefore carry reformulation costs and documentation burdens at each state boundary.

Policy-created opportunities in U.S. anti-reflective coatings

Section 45X of the Internal Revenue Code provides an advanced manufacturing production credit for domestically assembled solar modules, creating demand for AR-coated cover glass that raises module transmittance. Coaters that partner with domestic glass processors can sell into a credit-backed supply chain. Section 45X credits phase down from 2030 under current statute, so capacity commitments made before then capture the full value.

The U.S. Department of Veterans Affairs procures prescription and prosthetic eyewear through national contracting programs that specify AR-coated lenses for veteran eye care. Coaters supplying VA-approved laboratories can secure multi-year volume under federal contracts. Defense agencies also issue DPA Title III awards for night-vision and sighting optics, creating a second procurement channel for domestic thin-film capacity.

Market at a Glance

Leading Market Participants

• Essilor of America
• Hoya Vision Care
• Carl Zeiss Vision
• Shamir Insight
• Viavi Solutions
• Materion Corporation
• PPG Industries
• Corning Incorporated
• Edmund Optics
• Transitions Optical

Regulatory and Policy Environment

The principal legislation is the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), whose device provisions govern ophthalmic lenses, enforced by the FDA through 21 CFR Part 886 and 510(k) clearance. Chemical-level compliance falls under the Toxic Substances Control Act (15 U.S.C. 2601 et seq.), administered by the EPA Office of Pollution Prevention and Toxics. Key compliance obligations include PFAS use reporting under Section 8(a)(7), labeling under 21 CFR Part 801, and ANSI Z80.1-2020 optical performance testing.

Upcoming changes include the TSCA 8(a)(7) PFAS reporting window, which EPA has repeatedly deferred and remains the central compliance event, and Maine's categorical PFAS bans phasing in from January 1, 2026. Compared with regional peers, the U.S. framework relies on chemical reporting and state-level bans rather than the EU's proposed universal PFAS restriction under REACH (Regulation EC 1907/2006). Health Canada regulates lenses under the Medical Devices Regulations (SOR/98-282) with a lighter PFAS overlay.

Long-term policy outlook for U.S. anti-reflective coatings

By 2032, federal PFAS obligations will converge with state rules, pushing fluorine-free hydrophobic top coats across ophthalmic and display applications. CHIPS-funded fabs in Arizona and Ohio will reach full output, sustaining demand for precision AR-coated optics. This convergence will concentrate capacity among coaters with domestic thin-film lines and verified PFAS-free chemistry.

Trade policy will keep shaping sourcing, as Section 301 duties remain in force and further tariffs on Asian optical components will reshape lens-blank supply chains. Market value will shift toward defense, semiconductor, and solar applications, which together will expand faster than ophthalmic lenses across the forecast period.